An extraction pipeline for analysis of hematopoietic stem cell transplantation data [0.03%]
造血干细胞移植数据的分析提取管道
Erik G J von Asmuth,Constantijn J M Halkes,Jurjen Versluis et al.
Erik G J von Asmuth et al.
Many clinical studies are based on registry analyses, but exact approaches of data extraction and pre-processing are rarely included, while this is critical for reliability and reproducibility of results. We aimed to develop an open-source ...
Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country [0.03%]
低发病率国家allo-HSCT后造血干细胞移植受者肺结核患病率的十年全国病例对照研究
G Imbert de Trémiolles,S Nguyen,D Lebeaux et al.
G Imbert de Trémiolles et al.
Data regarding tuberculosis (TB) in allogeneic hematopoietic stem cell transplant (Allo-HSCT) recipients in low areas of incidence is scarce. The objectives were to describe incidence, risk factors, clinical manifestations, treatment and ou...
Bispecific antibodies followed by allogeneic hematopoietic stem cell transplantation as rescue therapy in refractory/relapsed B cell non-Hodgkin lymphoma: a real-life experience [0.03%]
双特异性抗体联合异基因造血干细胞移植治疗复发/难治性B细胞非霍奇金淋巴瘤的补救疗法：真实世界经验报告
Gabriele Facchin,Marta Lisa Battista,Jacopo Olivieri et al.
Gabriele Facchin et al.
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study [0.03%]
SARS-CoV-2 呼出时间在造血细胞移植受者中的研究：EBMT 感染病工作组研究结果
Malgorzata Mikulska,Gloria Tridello,Per Ljungman et al.
Malgorzata Mikulska et al.
Safe in transit: HSCT clinical outcomes unaffected by stem cell transport time [0.03%]
运输时间不影响脐带血移植临床疗效
Iwona Mitrus,Marcin Wilkiewicz,Wojciech Fidyk et al.
Iwona Mitrus et al.
Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement [0.03%]
慢性移植物抗宿主病的现状和未满足需求——欧洲立场声明
Florent Malard,Zinaida Peric,Annalisa Ruggeri et al.
Florent Malard et al.
Chronic graft-versus-host disease (cGVHD) remains the leading cause of late morbidity and non-relapse mortality after allogeneic hematopoietic cell transplantation, despite major advances in transplant techniques and supportive care. This E...
Yishan Ye,Eolia Brissot,Ali Bazarbachi et al.
Yishan Ye et al.
Higher-risk myelodysplastic syndrome (HR-MDS) is a heterogeneous group of hematopoietic malignancies primarily affecting the elderly, characterized by ineffective hematopoiesis, cytopenias, and a risk of transformation to acute myeloblastic...
Early safety of ruxolitinib as part of GVHD prophylaxis in mismatched unrelated donor HCT [0.03%]
mismatched无关供者的造血细胞移植(HCT)中芦可替尼作为预防GVHD一部分的早期安全性
Lauren Scarpetti,Yi-Bin Chen,Zachariah DeFilipp
Lauren Scarpetti
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party [0.03%]
EBMT急性白血病工作组研究：适应症为首次完全缓解的40岁以上成人急性淋巴细胞白血病患者的低强度预处理异基因造血干细胞移植中的抗胸腺细胞免疫球蛋白(ATG)或阿仑单抗为基础的移植物抗宿主病预防疗法
Gesine Bug,Myriam Labopin,Jennifer L Byrne et al.
Gesine Bug et al.
For patients with high-risk acute lymphoblastic leukemia (ALL), allogeneic hematopoietic cell transplantation (HCT) remains standard of care. In the setting of an HLA-matched unrelated donor HCT, in vivo T-cell depletion (TCD) for prophylax...
Correction: Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation [0.03%]
题图：采用放射性元素钇-89-抗cd66抗体对骨髓进行高效辐射并减少造血干细胞移植前对非血液系统器官的低摄取率
Kim Orchard,Jonathan Langford,Matthew Guy et al.
Kim Orchard et al.
Published Erratum
Bone marrow transplantation. 2026 Mar 4. DOI:10.1038/s41409-026-02810-7 2026